Abstract
Sixty children, with biopsy diagnosed focal segmental glomerulosclerosis (FSGS) and with unremitting nephrotic syndrome despite intensive therapy with adrenocortical steroids, were randomly allocated into a clinical trial comparing prednisone, 40 mg/m2 on alternate days for a period of 12 months (control group), with the same prednisone regimen plus a 90-day course of daily cyclophosphamide, 2.5 mg/kg in a single morning dose (experimental group). One-quarter of the children in each group had complete resolution of proteinuria. The proportions of children with increased, unchanged, and decreased proteinuria by the end of the study were the same in the two groups. Treatment fialure was defined as an increase in serum creatinine of 30% or more or greater than 0.4 mg/dl, or onset of renal failure. Treatment failure occurred in 36% of the control group and 57% of the experimental group (P>0.1). Five patients died during the trial, 3 in the experimental group and 2 in the control group. A Kaplan-Meier survival analysis revealed no significant differences between the two groups. Cyclophosphamide therapy for children with steroid-resistant FSGS is not recommended.
Similar content being viewed by others
References
Saint-Hiller Y, Morel-Maroger L, Woodrow D, Richet G (1975) Focal and segmental hyalinosis. Adv Nephrol 5: 67–88
Brown CB, Cameron JS, Turner DR, Chantler C, Ogg CS, Williams DG, Bewick M (1978) Focal segmental glomerulosclerosis with rapid decline in renal function (“malignant FSGS”). Clin Nephrol 10: 51–61
Mongeau JG, Corneille L, Robitaille P, O’Regan S, Pelletier M (1981) Primary nephrosis in childhood associated with focal glomerular sclerosis: is long-term prognosis that severe? Kidney Int 20: 743–746
Habib R, Gubler MC (1973) Focal sclerosing glomerulonephritis. In: Kincaid-Smith P, Mathew TH, Becker EL (eds) Glomerulonephritis: morphology, natural history, and treatment. Wiley, New York, p 263
Korbet SM, Schwartz MM, Lewis EJ (1994) Primary focal segmental glomerulosclerosis: clinical course and response to therapy. Am J Kidney Dis 23: 773–783
Beaufils H, Alphonse JC, Guedon J, Legrain M (1978) Focal glomerulosclerosis: natural history and treatment. Nephron 21: 75–85
Mongeau JG, Robitaille PO, Clermont MJ, Merouani A, Russo P (1993) Focal segmental glomerulosclerosis (FSG) 20 years later. From toddler to grown up. Clin Nephrol 40: 1–6
Cameron JS, Turner DR, Ogg CS, Chantler C, Williams DG (1978) The long-term prognosis of patients with focal segmental glomerulosclerosis. Clin Nephrol 10: 213–218
Niaudet P, Habib R, Gagnadoux MF, Tete MJ, Broyer M (1988) Treatment of severe childhood nephrosis. Adv Nephrol 17: 151–172
Banfi G, Moriggi M, Sabadini E, Fellin G, D’Amico G, Ponticelli C (1991) The impact of prolonged immunosuppression on the outcome of idiopathic focal-segmental glomerulosclerosis with nephrotic syndrome in adults. A collaborative retrospective study. Clin Nephrol 36: 53–59
Mendoza SA, Reznik VM, Griewold WR, Krensky AM, Yorgin PD, Tune BM (1990) Treatment of steroid resistant focal segmental glomerulosclerosis with pulse methylprednisolone and alkylating agents. Pediatr Nephrol 4: 303–307
Ponticelli C, Rizzoni G, Edefonti A, Altieri P, Rivolta E, Rinaldi S, Ghio L, Lusvarghi E, Gusmano R, Locatelli F, Pasquali S, Castellani A, Casa-Alberighi OD (1993) A randomized trial of cyclosporine in steroid-resistant idiopathic nephrotic syndrome. Kidney Int 43: 1377–1384
McEnery PT, Strife CF (1982) Nephrotic syndrome in childhood. Pediatr Clin North Am 89: 875–894
Geary DF, Farine M, Thorner P, Baumal R (1984) Response to cyclophosphamide in steroid-resistant focal segmental glomerulosclerosis: a reappraisal. Clin Nephrol 22: 109–113
Velosa JA, Torres VE, Donadio JV, Wagoner RD, Holley KE, Offord KP (1985) Treatment of severe nephrotic syndrome with meclofenamate: an uncontrolled pilot study. Mayo Clin Proc 60: 586–592
Meyrier A, Condamin MC, Broneer D, and the collaborative group of the French Society of Nephrology (1991) Treatment of adult idiopathic nephrotic syndrome with cyclosporin A: minimal change disease and focal segmental glomerulosclerosis. Clin Nephrol 35: S37-S42
Niaudet P, Broyer M, Habib R (1991) Treatment of idiopathic nephrotic syndrome with cyclosporin A in children. Clin Nephrol 35: S31-S36
Tune BM, Kirpekar R, Sibley RK, Reznik VM, Griswold WR, Mendoza SA (1995) Intravenous methylprednisolone and oral alkylating agent therapy of prednisone-resistant pediatric focal segmental glomerulosclerosis: a long-term follow-up. Clin Nephrol 43: 84–88
Habib R, Niaudet P (1994) Comparison between pre and post-treatment renal biopsies in children receiving cyclosporin for idiopathic nephrosis. Clin Nephrol 42: 141–146
Report of the International Study of Kidney Disease in Children (1974) Prospective, controlled trial of cyclophosphamide therapy in children with the nephrotic syndrome. Lancet II: 423–427
Report of the International Study of Kidney Disease in Children (1978) Nephrotic syndrome in children: prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. Kidney Int 13: 159–165
Churg J, Habib R, White RHR (1970) Pathology of the nephrotic syndrome in children: a report of the International Study of Kidney Disease in Children. Lancet I: 1299–1302
Zar JH (1984) Biostatistical analysis, 2nd edn. Prentice-Hall, Englewood Cliff, New Jersey
Cox DR, Oakes D (1984) Analysis of survival data. Chapman Hall, London
Report of the Southwest Pediatric Nephrology Study Group (1985) Focal segmental glomerulosclerosis in children with idiopathic nephrotic syndrome. Kidney Int 27: 442–449
Abramowicz M, Barnett HL, Edelmann CM, Greifer I, Kobayashi O, Arneil GC, Barron BA, Gordillo GP, Hallman N, Tiddens HA (1970) Controlled trial of azathioprine in children with nephrotic syndrome. A report for the International Study of Kidney Disease in Children. Lancet II: 959–961
Futrakul P, Posphyachinda M, Mitrakul C (1978) Focal sclerosing glomerulonephritis: a kinetic evaluation of hemostasis and the effect of anticoagulant therapy: a controlled study. Clin Nephrol 10: 180–186
Tejani A, Nicastri AD, Sen D, Chen CK, Phadke K, Adamson O, Butt KMH (1983) Long-term evaluation of children with nephrotic syndrome and focal segmental glomerular sclerosis. Nephron 35: 225–231
Habib R (1973) Focal glomerular sclerosis. Kidney Int 4: 355–361
Ingulli E, Singh A, Bagi N, Ahmad H, Moazami S, Tejani A (1995) Aggressive, long-term cyclosporine therapy for steroid-resistant focal segmental glomerulosclerosis. J Am Soc Nephrol 5: 1820–1825
Yoshikawa N, Ito H, Akamatsu R, Matsuyama S, Hasegawa O, Nakahara C, Matsuo T (1986) Focal segmental glomerulosclerosis with and without nephrotic syndrome in children. J Pediatr 109: 65–70
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tarshish, P., Tobin, J.N., Bernstein, J. et al. Cyclophosphamide does not benefit patients with focal segmental glomerulosclerosis. Pediatr Nephrol 10, 590–593 (1996). https://doi.org/10.1007/s004670050167
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s004670050167